FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976542221> ?p ?o ?g. }

• W1976542221 endingPage "309" @default.
• W1976542221 startingPage "300" @default.
• W1976542221 abstract "Stromelysins (matrix metalloproteinases: MMP-10 or ST-2 and MMP-11 or ST-3) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) have been shown to be associated with human tumor progression, invasion and metastasis. The aim of the present study was to determine the prognostic significance of these proteins in esophageal squamous cell carcinoma (ESCC).Immunohistochemical analysis was carried out in 65 surgically resected ESCCs and 49 distant histologically normal esophageal tissues and 16 cases of dysplasias. Statistical analyses were performed to determine the associations between the protein expression and clinicopathological parameters and survival of esophageal cancer patients.Expression of ST-2, ST-3, TIMP-1 and TIMP-2 was observed in 43/65 (66%), 51/65 (78%), 43/65 (66%) and 47/65 (72%) ESCC cases, respectively. Univariate analysis showed that TIMP-2 expression was associated with tumor site (OR = 2.63, p = 0.017). TIMP-1+/TIMP-2+ phenotype was inversely correlated with nodal invasiveness of the tumor (OR = 0.4, p = 0.04). Interestingly, p53 expression was associated with increased levels of ST-3 (OR = 0.11, p = 0.02) and TIMP-1 (OR = 3.2, p = 0.007) suggesting possible involvement of p53 in the regulation of these proteins. An increased expression of ST-2, ST-3, TIMP-1 and TIMP-2 was observed in 11/16 (69%), 7/17 (44%), 11/16 (69%) and 8/16 (50%) dysplasias also suggesting that these alterations are early events in esophageal tumorigenesis. All the ESCC patients were followed up postesophagectomy for a maximum period of 59 months (mean disease-free survival = 12 months). Kaplan-Meier survival analysis showed that patients with ST-3-positive and TIMP-2-negative carcinoma had a significantly shorter disease-free survival (median disease-free survival time of 4 months) as compared to patients in the other groups (median disease-free survival time of 20 months; p = 0.0016). To our knowledge this is the first report showing that ST-3+/TIMP-2- phenotype remained of significant predictive value for disease-free survival (p = 0.0007) in multivariate analysis including a conventional clinicopathological factor, tumor stage (p = 0.051).Our results suggest that ST-3+/TIMP-2- phenotype is an adverse prognosticator in esophageal cancer patients." @default.
• W1976542221 created "2016-06-24" @default.
• W1976542221 creator A5001997349 @default.
• W1976542221 creator A5035258801 @default.
• W1976542221 creator A5050945412 @default.
• W1976542221 creator A5054229964 @default.
• W1976542221 date "2004-01-01" @default.
• W1976542221 modified "2023-10-05" @default.
• W1976542221 title "Prognostic Significance of Stromelysin-3 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Esophageal Cancer" @default.
• W1976542221 cites W1505625682 @default.
• W1976542221 cites W1872370876 @default.
• W1976542221 cites W1874366132 @default.
• W1976542221 cites W190590421 @default.
• W1976542221 cites W1942960670 @default.
• W1976542221 cites W1976365078 @default.
• W1976542221 cites W1976435333 @default.
• W1976542221 cites W1984584032 @default.
• W1976542221 cites W1987542353 @default.
• W1976542221 cites W1996503037 @default.
• W1976542221 cites W1999258680 @default.
• W1976542221 cites W2006590541 @default.
• W1976542221 cites W2008745393 @default.
• W1976542221 cites W2009997132 @default.
• W1976542221 cites W2015359970 @default.
• W1976542221 cites W2022779216 @default.
• W1976542221 cites W2029137678 @default.
• W1976542221 cites W2032877238 @default.
• W1976542221 cites W2035122577 @default.
• W1976542221 cites W2035155128 @default.
• W1976542221 cites W2035548685 @default.
• W1976542221 cites W2037910534 @default.
• W1976542221 cites W2038087396 @default.
• W1976542221 cites W2043254359 @default.
• W1976542221 cites W2044924927 @default.
• W1976542221 cites W2047283411 @default.
• W1976542221 cites W2052372353 @default.
• W1976542221 cites W2070243575 @default.
• W1976542221 cites W2071515790 @default.
• W1976542221 cites W2072696107 @default.
• W1976542221 cites W2073392864 @default.
• W1976542221 cites W2080071965 @default.
• W1976542221 cites W2083214244 @default.
• W1976542221 cites W2090816469 @default.
• W1976542221 cites W2096353669 @default.
• W1976542221 cites W2119050264 @default.
• W1976542221 cites W2122374538 @default.
• W1976542221 cites W2134976853 @default.
• W1976542221 cites W2138178697 @default.
• W1976542221 cites W2155215427 @default.
• W1976542221 cites W3026060259 @default.
• W1976542221 doi "https://doi.org/10.1159/000081331" @default.
• W1976542221 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15557792" @default.
• W1976542221 hasPublicationYear "2004" @default.
• W1976542221 type Work @default.
• W1976542221 sameAs 1976542221 @default.
• W1976542221 citedByCount "29" @default.
• W1976542221 countsByYear W19765422212012 @default.
• W1976542221 countsByYear W19765422212013 @default.
• W1976542221 countsByYear W19765422212014 @default.
• W1976542221 countsByYear W19765422212016 @default.
• W1976542221 countsByYear W19765422212017 @default.
• W1976542221 countsByYear W19765422212021 @default.
• W1976542221 crossrefType "journal-article" @default.
• W1976542221 hasAuthorship W1976542221A5001997349 @default.
• W1976542221 hasAuthorship W1976542221A5035258801 @default.
• W1976542221 hasAuthorship W1976542221A5050945412 @default.
• W1976542221 hasAuthorship W1976542221A5054229964 @default.
• W1976542221 hasConcept C109523444 @default.
• W1976542221 hasConcept C121608353 @default.
• W1976542221 hasConcept C126322002 @default.
• W1976542221 hasConcept C142724271 @default.
• W1976542221 hasConcept C144301174 @default.
• W1976542221 hasConcept C204232928 @default.
• W1976542221 hasConcept C2775965246 @default.
• W1976542221 hasConcept C2777546739 @default.
• W1976542221 hasConcept C2777819096 @default.
• W1976542221 hasConcept C2779013556 @default.
• W1976542221 hasConcept C2779742542 @default.
• W1976542221 hasConcept C2780323790 @default.
• W1976542221 hasConcept C38180746 @default.
• W1976542221 hasConcept C502942594 @default.
• W1976542221 hasConcept C555283112 @default.
• W1976542221 hasConcept C55728118 @default.
• W1976542221 hasConcept C63363279 @default.
• W1976542221 hasConcept C71924100 @default.
• W1976542221 hasConceptScore W1976542221C109523444 @default.
• W1976542221 hasConceptScore W1976542221C121608353 @default.
• W1976542221 hasConceptScore W1976542221C126322002 @default.
• W1976542221 hasConceptScore W1976542221C142724271 @default.
• W1976542221 hasConceptScore W1976542221C144301174 @default.
• W1976542221 hasConceptScore W1976542221C204232928 @default.
• W1976542221 hasConceptScore W1976542221C2775965246 @default.
• W1976542221 hasConceptScore W1976542221C2777546739 @default.
• W1976542221 hasConceptScore W1976542221C2777819096 @default.
• W1976542221 hasConceptScore W1976542221C2779013556 @default.
• W1976542221 hasConceptScore W1976542221C2779742542 @default.
• W1976542221 hasConceptScore W1976542221C2780323790 @default.
• W1976542221 hasConceptScore W1976542221C38180746 @default.

• next